SynthesisClinical research in cardiology : official journal of the German Cardiac Society2014

Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials.

Simona Silvetti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.